… Our study is the 7th study to be published to date investigating the role of erlotinib in chordoma,
and the third using erlotinib … Here, we report the longest response duration to erlotinib …

… of any open-label, non-comparative study. However, indirect comparison between TRUST
and BR.21 provides further evidence that erlotinib can provide active disease control and …

… In this study, the difference in tissue concentration of erlotinib … Future comparative studies
between patients who developed … of focal tissue concentrations of erlotinib on rash formation. …

… Therefore, the present study evaluated the safety and efficacy of … Erlotinib in unresectable
esophageal carcinoma. In the present comparative study, we found that addition of Erlotinib to …

… study showed that the intermittent administration of erlotinib and docetaxel improved PFS, OS,
and disease control rate compared with erlotinib … docetaxel and erlotinib when given in an …

… Erlotinib administered in presence of proton pump inhibitors reduces its bioavailability
and C max by 46% and 61% respectively and if co-administered with ranitidine reduces …

… The present study investigates the efficacy of gemcitabine plus erlotinib (gem/erlotinib) in …
In the pivotal PA.3 trial, patients treated with gemcitabine plus erlotinib (gem/erlotinib) achieved …

… Our study revealed a significant benefit of erlotinib in patient with EGFRWT tumors compared
with other approaches. These findings add another therapeutic option to patients generally …

… erlotinib; hypersensitivity to erlotinib, afatinib, or the excipients of any of the trial drugs; major
surgery within 4 weeks of starting study treatment; previous participation in a clinical study …

… schedules of these agents, and not as a comparative study. … pulse erlotinib given
prechemotherapy in this study resulted … They hypothesize that administration of erlotinib at higher …